1-in-3 diabetics has a condition that leads to blindness. Our low-cost solution will diagnose it early and create $300m in US sales by 2020.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free